Articles Posted in DEA Defense

Our healthcare law firm works with many providers and healthcare practices who are facing an investigation from the Drug Enforcement Administration (DEA). This blog covers recent enforcement trends where the DEA has been investigating ketamine sellers that sell ketamine for at-home use. If you are being investigated by the DEA, the DEA has approached your practice, or you would like to discuss this blog post, you may contact our healthcare law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.

As we have discussed in prior blog posts, ketamine has been administered off-label to treat patients with treatment-resistant depression, and ketamine has gained popularity recently as a possible treatment option for treatment-resistant depression. Ketamine is a schedule III controlled substance, so ketamine is within the DEA’s and the Food and Drug Administration (FDA)’s purview. In June and July 2026, the FDA sent warning letters to Continue reading ›

Our healthcare law firm works with many providers and healthcare practices who are facing an investigation from the Drug Enforcement Administration (DEA). This blog covers the DEA’s storage and recordkeeping regulations if you are storing or administering controlled substances as part of your practice. This blog does not cover the DEA regulations for dispensing controlled substances from your practice, which is prescribing and giving patients controlled substances for at-home use, similar to what a pharmacy does. If you are being investigated by the DEA for possibly violating the DEA’s storage and recordkeeping regulations, the DEA has approached your practice, or you would like to discuss this blog post, you may contact our healthcare law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.

The DEA has implemented storage and recordkeeping regulations to protect against theft and diversion of controlled substances. The DEA requires Schedule II-V controlled substances to be stored in a “securely locked, substantially constructed cabinet.” As another requirement to protect against theft and diversion of controlled substances, the DEA prohibits practices and Continue reading ›